InMed Pharmaceuticals Inc. (MTRI) stock
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$19.87+1.27 (+6.83%)
Close on Nov 16, 2026Market cap $109.16MP/E –Yield –
InMed Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
InMed Pharmaceuticals's price to sales ratio was 0.4× on Apr 30, 2026, against 0.4× a year earlier. Over the last 4 years it ranged from 0.2× to 9.3×, with a median of 0.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 0.4× | −0.1 |
| 2025 | Dec 31, 2025 | 0.6× | −0.1 |
| 2024 | Dec 31, 2024 | 0.6× | +0.3 |
| 2023 | Dec 29, 2023 | 0.3× | −1.0 |
| 2022 | Dec 30, 2022 | 1.3× | −5.1 |
| 2021 | Oct 29, 2021 | 6.4× | – |
See a number that looks wrong?